Systemic and renal effects of preventing contrast nephrotoxicity with isotonic (0.9%) and hypotonic (0.45%) saline;Efectos renales y sistémicos en la prevención de la nefrotoxicidad por contraste con sueros salino (0,9%) e hiposalino (0,45%)

Revista Espanola de Cardiologia

Volumn 60, Issue 10, 2007, Pages 1018-1025

  Marrón, Belén ^a   Ruiz, Elisa ^b   Fernández, Cristina ^c   Almeida, Pedro ^d   Horcajada, Cristina ^d   Navarro, Felipe ^d   Caramelo, Carlos ^d  

^a Medical Affairs   (Spain)

^b HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Contrast nephrotoxicity; Hypotonic saline; Isotonic saline; Osmolality; Plasma volume; Renal protection

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; CONTRAST MEDIUM; ISOTONIC SOLUTION; SODIUM CHLORIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ELECTROLYTE BLOOD LEVEL; FEMALE; HEART VENTRICLE FUNCTION; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEPHROTOXICITY; OUTCOME ASSESSMENT; PLASMA VOLUME; RENAL PROTECTION; STANDARD; URINE OSMOLALITY;

ANALYSIS OF VARIANCE; BLOOD VOLUME; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DIURESIS; HEMATOCRIT; HEMOGLOBIN A; HUMANS; HYPOTONIC SOLUTIONS; ISOTONIC SOLUTIONS; KIDNEY DISEASES; PROSPECTIVE STUDIES; SERUM ALBUMIN; SODIUM CHLORIDE; SYSTOLE; TIME FACTORS;

EID: 37349095589     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13111233     Document Type: Article

References (32)

1. Katzberg RW. Urography into the 21st century: New contrast media, renal handling, imaging characteristics and nephrotoxicity. Radiology. 1997;204:297-312.
2. Solomon R. Radiocontrast induced nephropathy. Semin Nephrol. 1998;18:551-7.
3. Esplugas E, Molina C, Romero R, Martínez A, Anguera N, Olivella P. [Prospective study of the nephrotoxicity of iodized contrast in patients undergoing cardiac catheterization]. Rev Esp Cardiol. 1983;36:293-6.
4. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med. 1989;320:143-53.
5. Spinler SA, Goldfarb S. Nephrotoxicity of contrast media following cardiac angiography: Pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media. Ann Pharmacother. 1992;26:56-64.
6. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: Contrast media associated nephrotoxicity and atheroembolism. A critical review. Am J Kidney Dis. 1994;24:713-27.
7. Aspelin P, Aubry P, Fransson S, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high risk patients undergoing angiography. N Engl Med. 2003;348:491-9.
8. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media associated nephrotoxicity. Semin Nephrol. 1997;17:15-26.
9. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropaty. J Am Soc Nephrol. 2000;11:177-82.
10. Weisberg LS, KurniK PB, Kurnik BR. Dopamine and renal blood flow in radiocontrast induced nephropathy in humans. Renal Failure. 1993;15:61-8.
11. Allaqaband S, Tumuluri R, Malik AM. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast induced nephropathy. Catheter Cardiovasc Interv. 2002;57:279-83.
12. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-20.
13. Weisberg LS, KurniK PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994;45:259-65.
14. Kurnik BRC, Weisberg LS, Cuttler IM, Kurnik PB. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. J Lab Clin Med. 1990;116:27-35.
15. Kurnik BRC, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast induced nephropathy. Am J Kidney Dis. 1998;31:674-80.
16. Erley CM, Duda SH, Schlepckow S, Koehler J, Huppert PE, Strohmaier WL, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int. 1994;45:1425-31.
17. Bagshaw SM, Ghali WA. Theophylline for prevention of contrast induced nephropathy: a systematic review and meta-analysis. Arch Intern Med. 2005;165:1087-93.
18. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast media induced nephrotoxicity by the calcium channel blocker nitrendipine. A prospective randomised clinical trial. Nephrol Dial Transplant. 1989;4:1030-6.
19. Khoury Z, Schlicht JR, Como J, Karschner JK, Shapiro AP, MooK WJ. The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy. 1995;15:59-65.
20. Baker CSR, Wragg A, Kumar S, De Palma R, Baker LRI, Knight CJ. A rapid protocol for the prevention of contrast induced renal dysfuntion: The RAPPID Study. J Am Coll Cardiol. 2003;41: 2114-8.
21. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of impact of n-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366-74.
22. Teruel JL, Marcén R, Herrero JA, Felipe C, Ortuño J. An easy effective procedure to prevent radiocontrast agent nephrotoxicity in high risk patients. Nephron. 1989;51:282.
23. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild to moderate renal dysfunction. Chest. 1998;114:1570-4.
24. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial asses the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:C29-34.
25. Krasuski RA, Beard BM, Geoghagan JD, Thompson CM, Guidera SA. Optimal timing of hydratation to erase contrast-associated nephropathy: the OTHER CAN study. J invasive Cardiol. 2003;15:699-702.
26. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T. What is the best hydratation regimen to prevent contrast media induced nephrotoxicity? Clin Nephrol. 2004;62:1-7.
27. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media associated nephropathy. Arch Intern Med. 2002;162:329-36.
28. National Kidney Foundation. K/DOQI Clinical Practice Guide lines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002;39:S1-266.
29. Sarda IR, De Bold ML, De Bold AJ. Optimization of atrial natriurético factor immunoassay. Clin Biochem. 1989;22:11-5.
30. Beaumont WV. Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol. 1972;31:712-3.
31. Koomans HA, Geers AB, Boer P, Roos JC, Dorhout-Mees EJ. A study on the distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: preferential intravascular deposition in renal failure. Clin Sci. 1983;64:153-60.
32. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast induced nephropathy with sodium bicarbonate. JAMA. 2004;291:2328-34.